Menveo
Meningococcal conjugate vaccine tetravalent ( type A,C, Y, W-135)
Product Details
WHO Product ID
FVP-P-267
Status
Prequalified
Date of prequalification
Vaccine type
Meningococcal conjugate vaccine tetravalent ( type A,C, Y, W-135)
Abbreviated Name
MenACYW-135
Commercial Name
Menveo
PQ Holder
GlaxoSmithKline Vaccines S.r.l.
Via Fiorentina 1
Siena,
53100
Italy
Responsible NRA
European Medicines Agency
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with liquid active component before use
Presentation
Two vial set (active + active)
Number of doses
1
Route of administration
Intramuscular
Vaccine Vial Monitor
Type 14
Multidose Vial Policy
Not applicable
Shelf life (months)
36 months
Storage temperature
2 - 8°C
Diluent
Liquid active component
Preservative
None
Product Packaging
Secondary Container
Shipping Container
Component Packed
Active (Vaccine)
Total doses
10
Description
carton of 10 vials (5 doses) [4.2 x 4.4 x 8.8 cm]
Dimensions
4.2 x 4.4 x 8.8 cm
Cold Chain Volume (cm³/dose)
32.52